INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,604,715 | -23.4% | 50,750 | -1.3% | 0.51% | -19.2% |
| Q2 2023 | $2,096,092 | +21.6% | 51,400 | +11.1% | 0.63% | +15.6% |
| Q1 2023 | $1,724,297 | +8.2% | 46,265 | +1.3% | 0.54% | -2.0% |
| Q4 2022 | $1,593,252 | -32.1% | 45,665 | +8.8% | 0.56% | -33.5% |
| Q3 2022 | $2,348,000 | +5.0% | 41,965 | -2.9% | 0.84% | +8.6% |
| Q2 2022 | $2,237,000 | -30.7% | 43,225 | -2.8% | 0.77% | -20.2% |
| Q1 2022 | $3,230,000 | -42.5% | 44,450 | -6.5% | 0.96% | -32.7% |
| Q4 2021 | $5,619,000 | -17.8% | 47,525 | -6.7% | 1.43% | -13.4% |
| Q3 2021 | $6,835,000 | -13.2% | 50,950 | +4.7% | 1.65% | -6.9% |
| Q2 2021 | $7,877,000 | +71.0% | 48,650 | -32.1% | 1.78% | +40.4% |
| Q1 2021 | $4,606,000 | +28.4% | 71,625 | +8.6% | 1.26% | +17.9% |
| Q4 2020 | $3,586,000 | +294.9% | 65,925 | +44.4% | 1.07% | +212.8% |
| Q3 2020 | $908,000 | – | 45,650 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |